Current
ACIP Recommendations for Use of Recombinant Zoster Vaccine (RZV, Shingrix, GSK) in Immunocompromised Adults aged 19 years and older, US, 2022
MMWR, January 21, 2022, 71(3);80-84
Current
Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
MMWR, January 26, 2018; 67(3); 103–108
Archived
Update on Recommendations for Use of Herpes Zoster Vaccine
MMWR, August 22, 2014; 63(33):729-731
Current
Prevention of Herpes Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, June 6, 2008; 57(05):1-30